The Use of Isoproterenol in the Treatment of the Acute Asthmatic Attack with Report of Case

References

• Livingstone J. L., Davies J. P. Steroids in the long‐term treatment of asthma. Lancet 1961; 1: 1310–1314
   Google Scholar
• Collins‐Williams C., Hughes K. M. Treatment of the acutely ill asthmatic child. Ann. Allerg 1968; 26: 117–125
   PubMedGoogle Scholar
• Marchand P., van Hassett H. Last‐resort treatment of status asthmaticus. Lancet 1966; 1: 227–230
   PubMed Web of Science ®Google Scholar
• Leading Article: Death from asthma. Lancet 1968; 1: 1412
   Google Scholar
• Smith J. M. Prevalence and natural history of asthma in school children. Brit. Med. J. 1961; 1: 711–713
   Google Scholar
• Arbeiter H. I. How prevalent is allergy among United States school children? A survey of findings in the Munster (Indiana) School System. Clin. Pediat. 1967; 6: 140–142
   Google Scholar
• Logan B. B. Editorials: Asthma as a lethal disease. Amer. J. Dis. Child. 1965; 110: 1–2
   PubMedGoogle Scholar
• World Health Organization. Epidemiological and Vital Statistics Report. II. Special Subject, Bronchial Asthma 1951–1964. Epidem. vital Statist Rep. 1966; 19: 525–536
   Google Scholar
• Gandevia B. Pressurized aerosols in asthma. Brit. Med. J. 1967; 1: 441
   Google Scholar
• Gandevia B. The changing pattern of mortality from asthma in Australia: 2. Mortality and modern therapy. Med. J. Aust. 1968; 1: 884–891
   PubMedGoogle Scholar
• Editorial: Death in asthma. Med. J. Aust. 1968; 1: 907–908
   Google Scholar
• Smith J. M. Death from asthma. Lancet 1966; 1: 1042
   Web of Science ®Google Scholar
• Kerr J. W. Deaths from asthma. Brit. Med. J. 1967; 1: 177–178
   Google Scholar
• Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Brit. Med. J. 1968; 1: 335–339
   PubMed Web of Science ®Google Scholar
• Speizer F. E., Doll R., Heaf P., Strang L. B. Investigation into use of drugs preceding death from asthma. Brit. Med. J. 1968; 1: 339–343
   PubMed Web of Science ®Google Scholar
• Doll R., Speizer F., Heaf P., Strang L. Increased deaths from asthma. Brit. Med. J. 1967; 2: 756
   Google Scholar
• Richards W., Patrick J. R. Death from asthma in children. Amer. J. Dis. Child. 1965; 110: 4–23
   PubMedGoogle Scholar
• Read J. The reported increase in mortality from asthma: A clinical‐functional analysis. Med. J. Aust. 1968; 1: 879–884
   PubMedGoogle Scholar
• Dworetzky M., Philson A. D. Review of asthmatic patients hospitalized in the pavilion service of The New York Hospital from 1948 to 1963, with emphasis on mortality rate. J. Allerg. 1968; 41: 181–194
   PubMedGoogle Scholar
• Tai E., Read J. Blood‐gas tensions in bronchial asthma. Lancet 1967; 2: 644–646
   Google Scholar
• Annotations: Sympathomimetic drugs in asthma. Lancet 1967; 2: 1243
   Google Scholar
• Tai E., Read J. Response of blood gas tensions to aminophylline and isoprenaline in patients with asthma. Thorax. 1967; 22: 543–549
   PubMed Web of Science ®Google Scholar
• Rees H. A., Millar J. S., Donald K. W. Adrenaline in bronchial asthma. Lancet 1967; 2: 1164–1167
   PubMed Web of Science ®Google Scholar
• Rees H. A., Borthwick R. C., Millar J. S., Donald K. W. Aminophylline in bronchial asthma. Lancet 1967; 2: 1167–1169
   Google Scholar
• Palmer K. N. V., Diament M. L. Effect of aerosol isoprenaline on blood‐gas tensions in severe bronchial asthma. Lancet 1967; 2: 1232–1233
   PubMed Web of Science ®Google Scholar
• Palmer K. N. V. Spirometry and blood‐gas tensions in bronchial asthma and chronic bronchitis. Lancet 1967; 2: 383–384
   PubMed Web of Science ®Google Scholar
• Knudson R. J., Constantine H. P. An effect of isoproterenol on ventilation‐perfusion in asthmatic versus normal subjects. J. Appl. Physiol. 1967; 22: 402–406
   PubMed Web of Science ®Google Scholar
• Daly J. J., Howard P. Effect of intravenous aminophylline on the arterial oxygen saturation in chronic bronchitis. Thorax. 1965; 20: 324–326
   PubMed Web of Science ®Google Scholar
• Field G. B. The effects of posture, oxygen, isoproterenol and atropine on ventilation‐perfusion relationships in the lung in asthma. Clin. Sci. 1967; 32: 279–288
   PubMed Web of Science ®Google Scholar
• Leading Article: Increasing deaths from asthma. Brit. Med. J. 1968; 1: 329–330
   Google Scholar
• Dornhorst A. C., Hodge R. L. Pressurized aerosols in asthma. Brit. Med. J. 1967; 2: 441
   Google Scholar
• Edwards G. Pressurized aerosols in asthma. Brit. Med. J. 1967; 2: 239–240
   Google Scholar
• Pickvance W. Pressurized aerosols in asthma. Brit. Med. J. 1967; 1: 756
   Google Scholar
• Goodman L. S., Gilman A. The Pharmacological Basis of Therapeutics3rd ed. The Macmillan Co., New York 1965; 495, 498
   Google Scholar
• Paterson J. W., Conolly M. E., Davies D. S., Dollery C. T. Isoprenaline resistance and the use of pressurized aerosols in asthma. Lancet 1968; 2: 426–429
   PubMed Web of Science ®Google Scholar
• Keighley J. F. Iatrogenic asthma associated with adrenergic aerosols. Ann. Intern. Med. 1966; 65: 985–995
   PubMed Web of Science ®Google Scholar
• Tothill A. Deaths from asthma. Brit. Med. J. 1968; 1: 837–838
   Google Scholar
• Annotations: Adrenaline and isoprenaline in myocardial failure. Lancet 1965; 2: 122
   Google Scholar
• Read J., Fowler K. T. Effect of exercise on zonal distribution of pulmonary blood flow. J. Appl. Physiol. 1964; 19: 672–678
   Google Scholar
• Martindale W. Extra Pharmacopoeia25th ed., R. G. Todd. The Pharmaceutical Press, London 1967; 65
   Google Scholar
• Lockett M. F. Dangerous effects of isoprenaline in myocardial failure. Lancet 1965; 2: 104–106
   Google Scholar
• Ross D. The interval management of asthma. Med. J. Aust. 1957; 1: 130–132
   Google Scholar
• Hamilton D. G. The asthmatic child. Med. J. Aust. 1958; 2: 589–592
   Google Scholar
• McManis A. G. Adrenaline and isoprenaline: A warning. Med. J. Aust. 1964; 2: 76
   Google Scholar
• Graham O. A., Shields W. O'N. Cardiac arrest in bronchial asthma. Med. J. Aust. 1965; 1: 524
   Google Scholar
• Greenberg M. J., Pines A. Pressurized aerosols in asthma. Brit. Med. J. 1967; 1: 563
   PubMedGoogle Scholar
• Greenberg M. J. Isoprenaline in myocardial failure. Lancet 1965; 2: 442–443
   Google Scholar
• Millar M., Semple T. Cardiac arrest in asthma. Brit. Med. J. 1967; 3: 498
   Google Scholar
• Exon P. D. Pressurized aerosols in asthma. Brit. Med. J. 1967; 2: 178
   Google Scholar
• Today's Drugs: Aerosols in asthma and vaccines. Brit. Med. J. 1967; 2: 37
   Google Scholar
• Williams R. G. Adrenaline and isoprenaline: A warning. Med. J. Aust. 1964; 2: 161
   Google Scholar
• Herxheimer H. Isoprenaline in myocardial failure. Lancet 1965; 2: 298
   Google Scholar
• Kennedy M. C. S. Isoprenaline in myocardial failure. Lancet 1965; 2: 689
   Google Scholar
• Dees S. C., Personal Communication
   Google Scholar
• Howard W. A., Personal communication
   Google Scholar
• Crawford L. V., Personal communication
   Google Scholar
• Falliers C. J., Personal communication
   Google Scholar
• Herman B. A., Personal communication
   Google Scholar
• McGovern J. P., Personal communication
   Google Scholar
• Scott R. B., Personal communication
   Google Scholar
• Strem E. S., Personal communication
   Google Scholar
• Lecks H. I., Personal communication
   Google Scholar
• Siegel S. C., Personal communication
   Google Scholar
• Engstrom I., Personal communication
   Google Scholar
• Kraepelien S., Personal communication
   Google Scholar